Slide 1 - Flash (Medium) - 20121119 02.40.03PM
X
Slide 1
Public Health: A Big Doctor?
Lead: Where is it?
Slide 4
Questions
Blood lead levels
Blood lead levels
Three compartment model of Pb metabolism (Rabinowitz et al. 1976)
Lead in blood vs. bone
How can we measure bone lead levels?: K X-ray Fluorescence (KXRF)
Population data on bone lead: the Normative Aging Study Hu et al. Am J Epidem, 1996
Bone Lead and Health Effects
Traditional Epidemiology
Gene-Environment Interaction
Why gene-environment interaction?
Genes in the iron pathway and lead
Iron metabolism and HFE
Slide 18
Slide 19
Pathway Analysis
Haplotype analysis for TFR2
Nutrition-Environment Interaction
Why nutrition-environment interaction?
Homocysteine and B vitamins
Low cardiovascular risk: low inflammation, less atherosclerosis
Lead exposure and Plasma total Hcy
Analyses stratified by diet
Does exposure during adulthood matter?
Slide 30
Life-long exposure to lead and health
Summary
Thank you for your attention!!!
Summary
Life-long exposure to lead and health
Slide 30
Does exposure during adulthood matter?
Analyses stratified by diet
Lead exposure and Plasma total Hcy
Low cardiovascular risk: low inflammation, less atherosclerosis
Homocysteine and B vitamins
Why nutrition-environment interaction?
Nutrition-Environment Interaction
Haplotype analysis for TFR2
Pathway Analysis
Slide 19
Slide 18
Iron metabolism and HFE
Genes in the iron pathway and lead
Why gene-environment interaction?
Gene-Environment Interaction
Traditional Epidemiology
Bone Lead and Health Effects
Population data on bone lead: the Normative Aging Study Hu et al. Am J Epidem, 1996
How can we measure bone lead levels?: K X-ray Fluorescence (KXRF)
Lead in blood vs. bone
Three compartment model of Pb metabolism (Rabinowitz et al. 1976)
Blood lead levels
Blood lead levels
Blood lead levels
Three compartment model of Pb metabolism (Rabinowitz et al. 1976)
Lead in blood vs. bone
How can we measure bone lead levels?: K X-ray Fluorescence (KXRF)
Population data on bone lead: the Normative Aging Study Hu et al. Am J Epidem, 1996
Bone Lead and Health Effects
Traditional Epidemiology
Gene-Environment Interaction
Why gene-environment interaction?
Genes in the iron pathway and lead
Iron metabolism and HFE
Slide 18
Slide 19
Pathway Analysis
Haplotype analysis for TFR2
Nutrition-Environment Interaction
Why nutrition-environment interaction?
Homocysteine and B vitamins
Low cardiovascular risk: low inflammation, less atherosclerosis
Lead exposure and Plasma total Hcy
Analyses stratified by diet
Does exposure during adulthood matter?
Slide 30
Life-long exposure to lead and health
Summary
Thank you for your attention!!!
Calcium, iron and BLLs
Does stress enhance the lead toxicity?
00:00
/
00:00
CC
Lead
and
Health:
A
Never-Ending
Story
Epidemiology
Seminar
Series
November
15,
2012
Sung
Kyun
Park,
Sc.D.
Department
of
Epidemiology
University
of
Michigan
School
of
Public
Health
Email:
sungkyun@umich.edu
1
Public
Health:
A
Big
Doctor?
소의
(小醫,
small
doctor),
중의
(中醫,
medium
doctor),
대의
(大醫,
big
doctor):
A
small
doctor
cures
a
disease,
a
medium
doctor
cures
a
human,
and
a
big
doctor
cures
a
society
(country)
小醫治病,
中醫治人,
大醫治國
Dongui
Bogam
(동의보감,
東醫寶鑑)
Lead:
Where
is
it?
3
http://blogs.webmd.com/healthy-children/uploaded_images/amjph00238-0084-712905.gif
http://blogs.webmd.com/healthy-children/uploaded_images/amjph00238-0084-712901.gif
http://blogs.webmd.com/healthy-children/uploaded_images/recall_train-771999.jpg
http://blogs.webmd.com/healthy-children/uploaded_images/recall_train-771995.jpg
Children's
lead
poisoning
drops
but
exposure
remains
most
common
among
poor
http://upload.wikimedia.org/wikipedia/commons/thumb/9/92/Calcite-Galena-elm56c.jpg/170px-Calcite-Galena-elm56c.jpg
http://upload.wikimedia.org/wikipedia/commons/thumb/8/8a/Lead_glazed_ceramic_cup_Tang_China_8th_century.jpg/220px-Lead_glazed_ceramic_cup_Tang_China_8th_century.jpg
http://lead-alloy.com/yahoo_site_admin/assets/images/7images_pipes1.7131807_std.jpg
http://www.earthyreport.com/site/wp-content/uploads/2011/10/leaded.gif
0.2
–
0.8
0.9
–
1.3
1.4
–
1.8
1.9
–
2.8
>
2.8
90th:
3.7
µg/dL
95th:
4.8
99th:
9.0
EHP
2012;120:1544-1550
P
for
trend
<
0.001
Similar
trends
were
found
between
blood
lead
and
hypertension
(blood
pressure),
renal
disease,
cognitive
declines,
etc.
Lead
standard:
10
µg/dL
for
children
and
pregnant
women
Questions
Does
the
toxic
effect
of
lead
on
chronic
diseases
begin
at
3
µg/dL
or
even
lower
levels?
or
Does
blood
lead
levels
found
in
adults
today
(especially
old
persons)
reflect
past,
cumulative
lifetime
exposure?
Blood
lead
levels
fig3
NHANES-III
2.76
g/dL
NHANES
99-02
1.64
g/dL
6
Blood
lead
levels
fig3
NHANES-III
2.76
g/dL
NHANES
99-02
1.64
g/dL
7
Three
compartment
model
of
Pb
metabolism
(Rabinowitz
et
al.
1976)
Diet
&
Air
3
BONE
~20-50*
yrs
1
BLOOD
36
±
5
days
2
SOFT
TISSUE
~40
days
URINE
BILE,
HAIR,
SWEAT,
NAILS
90-95%
of
body
lead
burden
resides
in
bone
in
adults
*from
Wilker
et
al.
JOEM
2011
Lead
in
blood
vs.
bone
9
CONCEPT
EHP
figure-1
Hu
et
al.,
EHP
1998
How
can
we
measure
bone
lead
levels?:
K
X-ray
Fluorescence
(KXRF)
KXRF
room
in
SPH-1
G832
(Picture
courtesy
of
K
Bakulski,
Ph.D.)
Slide31
Non-invasive
Safe
(radiation
dose
in
microsieverts)
Convenient
(30
minutes/measure)
Population
data
on
bone
lead:
the
Normative
Aging
Study
Hu
et
al.
Am
J
Epidem,
1996
07_MensChorus
A
Boston-based
longitudinal
study
of
aging
begun
in
1962:
normal
men,
95%
white,
18-80yo,
all
social
classes
Mean
age
of
67
yrs
at
the
time
of
bone
lead
test
http://3.bp.blogspot.com/_F2xmLAzQ8Ho/Sowqm6t9zWI/AAAAAAAAEcE/Kpfc35t4Yoc/s200/va_seal.jpg
Bone
Lead
and
Health
Effects
Associated
with
High
blood
pressure
(hypertension)
Pulse
pressure
and
ischemic
heart
disease
EKG
abnormalities
(e.g.,
QT
intervals)
Total
and
CVD
Mortality
Renal
function
(serum
creatinine)
Cognitive
declines
Mental
health
Age-related
cataract
Age-related
hearing
loss
Plasma
homocysteine
(ms
in
prep
by
Kelly
Bakulski)
Type-2
diabetes
(ms
in
prep
by
Siying
Huang)
Traditional
Epidemiology
Exposure
Disease
Molecular
Epidemiology
Exposure
Internal
Dose
Biologically
Effective
Dose
Early
Biologic
Effect
Altered
Structure/
Function
Clinical
Disease
Prognostic
Significance
Markers
of
Susceptibility
.
.
.
.
.
Markers
of
Exposure
.
.
.
.
.
.
Markers
of
Disease
Schulte
and
Perera,
1993
Gene-Environment
Interaction
Why
gene-environment
interaction?
Disease
are
multifactorial
Elucidate
of
biological
mechanisms
Identify
susceptible
populations
Genes
in
the
iron
pathway
and
lead
Why
iron?
Iron
metabolism
and
HFE
Iron
homeostasis
HFE
(hemochromatosis):
iron
overload
C282Y
(cysteine
tyrosine
at
282)
H63D
(histidine
aspartate
at
63)
Molecular
mechanism
17
Tf
Fe
Fe
TfR
TfR
HFE
2
Wild-type
HFE
Tf
Fe
Fe
2
C282Y
homozygous
HFE
HFE
TfR
TfR
Tf
Fe
Fe
18
(EHP
2007;115:1210-1215)
Adjust
for
age,
education,
smoking,
alcohol,
first
language,
computer
experience,
diabetes
P
for
interaction=0.03
Adjust
for
age,
education,
smoking,
alcohol
consumption,
daily
intakes
of
calcium,
sodium,
and
potassium,
calorie,
physical
activity,
diabetes,
family
history
of
HTN,
HDL,
total
cholesterol,
waist
circumference
(EHP
2010;118:1261-6)
19
Pathway
Analysis
Why
Pathway
analysis?
GWAS
or
SNP-based
candidate
gene
approach:
needle
in
a
haystack
The
testing
unit:
an
SNP
If
multiple
SNPs
in
a
pathway
contribute
to
disease
susceptibility,
but
individually
each
SNP
has
a
relatively
small
effect,
the
single-SNP
association
could
be
too
weak
to
be
detected
Pathway
analysis
combines
association
evidence
from
multiple
genetic
variants
and
thus
potentially
has
a
better
chance
of
identifying
the
association
of
interest
The
testing
unit:
a
gene
(multiple
SNPs)
or
a
pathway
(multiple
genes)
Haplotype
analysis
for
TFR2
Nutrition-Environment
Interaction
Why
nutrition-environment
interaction?
Elucidation
of
biological
mechanisms
Exposure
already
happened.
What
can
we
do?
An
economical
intervention
tool
Homocysteine
and
B
vitamins
Homocysteine:
an
intermediate
product
of
the
one
carbon
metabolism
B
vitamins:
cofactors
that
contribute
to
Hcy
synthesis,
CH3
transfer
25
Intakes
Folate
Low
cardiovascular
risk:
low
inflammation,
less
atherosclerosis
ins5
Lead
exposure
and
Plasma
total
Hcy
Bakulski
et
al.,
(ms
in
preparation)
27
Analyses
stratified
by
diet
Mixed
Effects
Model,
Random:
intercept
and
slope
Log(Hcy)
=
β0
+
β1(blood
Pb)
+
β2(time)
+
β3(baseline
age)
+
β4(baseline
age
*
time)
+
βxCov
+
ε
stratifiedflipboth
copy.tiff
stratifiedfliplowonly
copy.tiff
Folate
Folate
B12
B12
B6
B6
Slide
Courtesy
of
kelly
bakulski,
ph.d.
Bakulski
et
al.,
(ms
in
preparation)
Does
exposure
during
adulthood
matter?
Wu
et
al.,
J
Neurosci
2008
23-yr
old
monkeys
EHP
2012;120:445-450
Differences
in
BP
b/w
women
and
men
across
young
and
middle
age
may
stem
from
increased
likelihood
of
prenatal
lead
exposure?
Life-long
exposure
to
lead
and
health
science?_ob=MiamiCaptionURL&_method=retrieve&_udi=B6WXH-4PF6B3N-2&_image=B6WXH-4PF6B3N-2-B&_ba=&_user=99318&_rdoc=1&_fmt=full&_orig=search&_cdi=7159&view=c&_isHiQual=Y&_acct=C000007678&_version=1&_urlVersion=0&_userid=99318&md5=7a454c3abec06c7689e5398bb579b9fd
White
et
al,
Toxicol
Appl
Pharm
2007
Neonatal+Adult
exposure
+Healthy
lifestyle
Summary
Health
effects
of
lead
are
not
over
not
a
past
problem
but
an
ongoing
problem
There
are
more
susceptible
populations
to
lead
exposure
The
findings
from
nutrition-lead
and
stress-lead
interactions
suggest
that
healthy
lifestyle
is
important
to
reduce
potential
adverse
health
effects
of
lead
Developmental
period
as
a
window
of
susceptibility
to
lead
Thank
you
for
your
attention!!!
Questions?
Summary
Health
effects
of
lead
are
not
over
not
a
past
problem
but
an
ongoing
problem
There
are
more
susceptible
populations
to
lead
exposure
The
findings
from
nutrition-lead
and
stress-lead
interactions
suggest
that
healthy
lifestyle
is
important
to
reduce
potential
adverse
health
effects
of
lead
Developmental
period
as
a
window
of
susceptibility
to
lead
Life-long
exposure
to
lead
and
health
science?_ob=MiamiCaptionURL&_method=retrieve&_udi=B6WXH-4PF6B3N-2&_image=B6WXH-4PF6B3N-2-B&_ba=&_user=99318&_rdoc=1&_fmt=full&_orig=search&_cdi=7159&view=c&_isHiQual=Y&_acct=C000007678&_version=1&_urlVersion=0&_userid=99318&md5=7a454c3abec06c7689e5398bb579b9fd
White
et
al,
Toxicol
Appl
Pharm
2007
Neonatal+Adult
exposure
+Healthy
lifestyle
EHP
2012;120:445-450
Differences
in
BP
b/w
women
and
men
across
young
and
middle
age
may
stem
from
increased
likelihood
of
prenatal
lead
exposure?
Does
exposure
during
adulthood
matter?
Wu
et
al.,
J
Neurosci
2008
23-yr
old
monkeys
Analyses
stratified
by
diet
Mixed
Effects
Model,
Random:
intercept
and
slope
Log(Hcy)
=
β0
+
β1(blood
Pb)
+
β2(time)
+
β3(baseline
age)
+
β4(baseline
age
*
time)
+
βxCov
+
ε
stratifiedflipboth
copy.tiff
stratifiedfliplowonly
copy.tiff
Folate
Folate
B12
B12
B6
B6
Slide
Courtesy
of
kelly
bakulski,
ph.d.
Bakulski
et
al.,
(ms
in
preparation)
Lead
exposure
and
Plasma
total
Hcy
Bakulski
et
al.,
(ms
in
preparation)
27
Low
cardiovascular
risk:
low
inflammation,
less
atherosclerosis
ins5
Homocysteine
and
B
vitamins
Homocysteine:
an
intermediate
product
of
the
one
carbon
metabolism
B
vitamins:
cofactors
that
contribute
to
Hcy
synthesis,
CH3
transfer
25
Intakes
Folate
Why
nutrition-environment
interaction?
Elucidation
of
biological
mechanisms
Exposure
already
happened.
What
can
we
do?
An
economical
intervention
tool
Nutrition-Environment
Interaction
Haplotype
analysis
for
TFR2
Pathway
Analysis
Why
Pathway
analysis?
GWAS
or
SNP-based
candidate
gene
approach:
needle
in
a
haystack
The
testing
unit:
an
SNP
If
multiple
SNPs
in
a
pathway
contribute
to
disease
susceptibility,
but
individually
each
SNP
has
a
relatively
small
effect,
the
single-SNP
association
could
be
too
weak
to
be
detected
Pathway
analysis
combines
association
evidence
from
multiple
genetic
variants
and
thus
potentially
has
a
better
chance
of
identifying
the
association
of
interest
The
testing
unit:
a
gene
(multiple
SNPs)
or
a
pathway
(multiple
genes)
Adjust
for
age,
education,
smoking,
alcohol
consumption,
daily
intakes
of
calcium,
sodium,
and
potassium,
calorie,
physical
activity,
diabetes,
family
history
of
HTN,
HDL,
total
cholesterol,
waist
circumference
(EHP
2010;118:1261-6)
19
18
(EHP
2007;115:1210-1215)
Adjust
for
age,
education,
smoking,
alcohol,
first
language,
computer
experience,
diabetes
P
for
interaction=0.03
Iron
metabolism
and
HFE
Iron
homeostasis
HFE
(hemochromatosis):
iron
overload
C282Y
(cysteine
tyrosine
at
282)
H63D
(histidine
aspartate
at
63)
Molecular
mechanism
17
Tf
Fe
Fe
TfR
TfR
HFE
2
Wild-type
HFE
Tf
Fe
Fe
2
C282Y
homozygous
HFE
HFE
TfR
TfR
Tf
Fe
Fe
Genes
in
the
iron
pathway
and
lead
Why
iron?
Why
gene-environment
interaction?
Disease
are
multifactorial
Elucidate
of
biological
mechanisms
Identify
susceptible
populations
Gene-Environment
Interaction
Traditional
Epidemiology
Exposure
Disease
Molecular
Epidemiology
Exposure
Internal
Dose
Biologically
Effective
Dose
Early
Biologic
Effect
Altered
Structure/
Function
Clinical
Disease
Prognostic
Significance
Markers
of
Susceptibility
.
.
.
.
.
Markers
of
Exposure
.
.
.
.
.
.
Markers
of
Disease
Schulte
and
Perera,
1993
Bone
Lead
and
Health
Effects
Associated
with
High
blood
pressure
(hypertension)
Pulse
pressure
and
ischemic
heart
disease
EKG
abnormalities
(e.g.,
QT
intervals)
Total
and
CVD
Mortality
Renal
function
(serum
creatinine)
Cognitive
declines
Mental
health
Age-related
cataract
Age-related
hearing
loss
Plasma
homocysteine
(ms
in
prep
by
Kelly
Bakulski)
Type-2
diabetes
(ms
in
prep
by
Siying
Huang)
Population
data
on
bone
lead:
the
Normative
Aging
Study
Hu
et
al.
Am
J
Epidem,
1996
07_MensChorus
A
Boston-based
longitudinal
study
of
aging
begun
in
1962:
normal
men,
95%
white,
18-80yo,
all
social
classes
Mean
age
of
67
yrs
at
the
time
of
bone
lead
test
http://3.bp.blogspot.com/_F2xmLAzQ8Ho/Sowqm6t9zWI/AAAAAAAAEcE/Kpfc35t4Yoc/s200/va_seal.jpg
How
can
we
measure
bone
lead
levels?:
K
X-ray
Fluorescence
(KXRF)
KXRF
room
in
SPH-1
G832
(Picture
courtesy
of
K
Bakulski,
Ph.D.)
Slide31
Non-invasive
Safe
(radiation
dose
in
microsieverts)
Convenient
(30
minutes/measure)
Lead
in
blood
vs.
bone
9
CONCEPT
EHP
figure-1
Hu
et
al.,
EHP
1998
Three
compartment
model
of
Pb
metabolism
(Rabinowitz
et
al.
1976)
Diet
&
Air
3
BONE
~20-50*
yrs
1
BLOOD
36
±
5
days
2
SOFT
TISSUE
~40
days
URINE
BILE,
HAIR,
SWEAT,
NAILS
90-95%
of
body
lead
burden
resides
in
bone
in
adults
*from
Wilker
et
al.
JOEM
2011
Blood
lead
levels
fig3
NHANES-III
2.76
g/dL
NHANES
99-02
1.64
g/dL
7
Blood
lead
levels
fig3
NHANES-III
2.76
g/dL
NHANES
99-02
1.64
g/dL
6
Blood
lead
levels
fig3
NHANES-III
2.76
g/dL
NHANES
99-02
1.64
g/dL
7
Three
compartment
model
of
Pb
metabolism
(Rabinowitz
et
al.
1976)
Diet
&
Air
3
BONE
~20-50*
yrs
1
BLOOD
36
±
5
days
2
SOFT
TISSUE
~40
days
URINE
BILE,
HAIR,
SWEAT,
NAILS
90-95%
of
body
lead
burden
resides
in
bone
in
adults
*from
Wilker
et
al.
JOEM
2011
Lead
in
blood
vs.
bone
9
CONCEPT
EHP
figure-1
Hu
et
al.,
EHP
1998
How
can
we
measure
bone
lead
levels?:
K
X-ray
Fluorescence
(KXRF)
KXRF
room
in
SPH-1
G832
(Picture
courtesy
of
K
Bakulski,
Ph.D.)
Slide31
Non-invasive
Safe
(radiation
dose
in
microsieverts)
Convenient
(30
minutes/measure)
Population
data
on
bone
lead:
the
Normative
Aging
Study
Hu
et
al.
Am
J
Epidem,
1996
07_MensChorus
A
Boston-based
longitudinal
study
of
aging
begun
in
1962:
normal
men,
95%
white,
18-80yo,
all
social
classes
Mean
age
of
67
yrs
at
the
time
of
bone
lead
test
http://3.bp.blogspot.com/_F2xmLAzQ8Ho/Sowqm6t9zWI/AAAAAAAAEcE/Kpfc35t4Yoc/s200/va_seal.jpg
Bone
Lead
and
Health
Effects
Associated
with
High
blood
pressure
(hypertension)
Pulse
pressure
and
ischemic
heart
disease
EKG
abnormalities
(e.g.,
QT
intervals)
Total
and
CVD
Mortality
Renal
function
(serum
creatinine)
Cognitive
declines
Mental
health
Age-related
cataract
Age-related
hearing
loss
Plasma
homocysteine
(ms
in
prep
by
Kelly
Bakulski)
Type-2
diabetes
(ms
in
prep
by
Siying
Huang)
Traditional
Epidemiology
Exposure
Disease
Molecular
Epidemiology
Exposure
Internal
Dose
Biologically
Effective
Dose
Early
Biologic
Effect
Altered
Structure/
Function
Clinical
Disease
Prognostic
Significance
Markers
of
Susceptibility
.
.
.
.
.
Markers
of
Exposure
.
.
.
.
.
.
Markers
of
Disease
Schulte
and
Perera,
1993
Gene-Environment
Interaction
Why
gene-environment
interaction?
Disease
are
multifactorial
Elucidate
of
biological
mechanisms
Identify
susceptible
populations
Genes
in
the
iron
pathway
and
lead
Why
iron?
Iron
metabolism
and
HFE
Iron
homeostasis
HFE
(hemochromatosis):
iron
overload
C282Y
(cysteine
tyrosine
at
282)
H63D
(histidine
aspartate
at
63)
Molecular
mechanism
17
Tf
Fe
Fe
TfR
TfR
HFE
2
Wild-type
HFE
Tf
Fe
Fe
2
C282Y
homozygous
HFE
HFE
TfR
TfR
Tf
Fe
Fe
18
(EHP
2007;115:1210-1215)
Adjust
for
age,
education,
smoking,
alcohol,
first
language,
computer
experience,
diabetes
P
for
interaction=0.03
Adjust
for
age,
education,
smoking,
alcohol
consumption,
daily
intakes
of
calcium,
sodium,
and
potassium,
calorie,
physical
activity,
diabetes,
family
history
of
HTN,
HDL,
total
cholesterol,
waist
circumference
(EHP
2010;118:1261-6)
19
Pathway
Analysis
Why
Pathway
analysis?
GWAS
or
SNP-based
candidate
gene
approach:
needle
in
a
haystack
The
testing
unit:
an
SNP
If
multiple
SNPs
in
a
pathway
contribute
to
disease
susceptibility,
but
individually
each
SNP
has
a
relatively
small
effect,
the
single-SNP
association
could
be
too
weak
to
be
detected
Pathway
analysis
combines
association
evidence
from
multiple
genetic
variants
and
thus
potentially
has
a
better
chance
of
identifying
the
association
of
interest
The
testing
unit:
a
gene
(multiple
SNPs)
or
a
pathway
(multiple
genes)
Haplotype
analysis
for
TFR2
Nutrition-Environment
Interaction
Why
nutrition-environment
interaction?
Elucidation
of
biological
mechanisms
Exposure
already
happened.
What
can
we
do?
An
economical
intervention
tool
Homocysteine
and
B
vitamins
Homocysteine:
an
intermediate
product
of
the
one
carbon
metabolism
B
vitamins:
cofactors
that
contribute
to
Hcy
synthesis,
CH3
transfer
25
Intakes
Folate
Low
cardiovascular
risk:
low
inflammation,
less
atherosclerosis
ins5
Lead
exposure
and
Plasma
total
Hcy
Bakulski
et
al.,
(ms
in
preparation)
27
Analyses
stratified
by
diet
Mixed
Effects
Model,
Random:
intercept
and
slope
Log(Hcy)
=
β0
+
β1(blood
Pb)
+
β2(time)
+
β3(baseline
age)
+
β4(baseline
age
*
time)
+
βxCov
+
ε
stratifiedflipboth
copy.tiff
stratifiedfliplowonly
copy.tiff
Folate
Folate
B12
B12
B6
B6
Slide
Courtesy
of
kelly
bakulski,
ph.d.
Bakulski
et
al.,
(ms
in
preparation)
Does
exposure
during
adulthood
matter?
Wu
et
al.,
J
Neurosci
2008
23-yr
old
monkeys
EHP
2012;120:445-450
Differences
in
BP
b/w
women
and
men
across
young
and
middle
age
may
stem
from
increased
likelihood
of
prenatal
lead
exposure?
Life-long
exposure
to
lead
and
health
science?_ob=MiamiCaptionURL&_method=retrieve&_udi=B6WXH-4PF6B3N-2&_image=B6WXH-4PF6B3N-2-B&_ba=&_user=99318&_rdoc=1&_fmt=full&_orig=search&_cdi=7159&view=c&_isHiQual=Y&_acct=C000007678&_version=1&_urlVersion=0&_userid=99318&md5=7a454c3abec06c7689e5398bb579b9fd
White
et
al,
Toxicol
Appl
Pharm
2007
Neonatal+Adult
exposure
+Healthy
lifestyle
Summary
Health
effects
of
lead
are
not
over
not
a
past
problem
but
an
ongoing
problem
There
are
more
susceptible
populations
to
lead
exposure
The
findings
from
nutrition-lead
and
stress-lead
interactions
suggest
that
healthy
lifestyle
is
important
to
reduce
potential
adverse
health
effects
of
lead
Developmental
period
as
a
window
of
susceptibility
to
lead
Thank
you
for
your
attention!!!
Questions?
Calcium,
iron
and
BLLs
Calcium
supplementation
during
pregnancy
on
maternal
BLLs:
a
RCT
Ettinger
et
al.,
EHP
2009
Iron
fortification
in
Children,
India
Zimmermann
et
al.,
Pediatrics
2006
Does
stress
enhance
the
lead
toxicity?
Peters
et
al.,
EHP
2007